Style | Citing Format |
---|---|
MLA | Ketabi A, et al.. "The Influence of Using Different Reconstruction Algorithms on Sensitivity of Quantitative 18F-Fdg-Pet Volumetric Measures to Background Activity Variation." Iranian Journal of Nuclear Medicine, vol. 26, no. 2, 2018, pp. 87-97. |
APA | Ketabi A, Ghafarian P, Moslehshirazi MA, Mahdavi SR, Ay MR (2018). The Influence of Using Different Reconstruction Algorithms on Sensitivity of Quantitative 18F-Fdg-Pet Volumetric Measures to Background Activity Variation. Iranian Journal of Nuclear Medicine, 26(2), 87-97. |
Chicago | Ketabi A, Ghafarian P, Moslehshirazi MA, Mahdavi SR, Ay MR. "The Influence of Using Different Reconstruction Algorithms on Sensitivity of Quantitative 18F-Fdg-Pet Volumetric Measures to Background Activity Variation." Iranian Journal of Nuclear Medicine 26, no. 2 (2018): 87-97. |
Harvard | Ketabi A et al. (2018) 'The Influence of Using Different Reconstruction Algorithms on Sensitivity of Quantitative 18F-Fdg-Pet Volumetric Measures to Background Activity Variation', Iranian Journal of Nuclear Medicine, 26(2), pp. 87-97. |
Vancouver | Ketabi A, Ghafarian P, Moslehshirazi MA, Mahdavi SR, Ay MR. The Influence of Using Different Reconstruction Algorithms on Sensitivity of Quantitative 18F-Fdg-Pet Volumetric Measures to Background Activity Variation. Iranian Journal of Nuclear Medicine. 2018;26(2):87-97. |
BibTex | @article{ author = {Ketabi A and Ghafarian P and Moslehshirazi MA and Mahdavi SR and Ay MR}, title = {The Influence of Using Different Reconstruction Algorithms on Sensitivity of Quantitative 18F-Fdg-Pet Volumetric Measures to Background Activity Variation}, journal = {Iranian Journal of Nuclear Medicine}, volume = {26}, number = {2}, pages = {87-97}, year = {2018} } |
RIS | TY - JOUR AU - Ketabi A AU - Ghafarian P AU - Moslehshirazi MA AU - Mahdavi SR AU - Ay MR TI - The Influence of Using Different Reconstruction Algorithms on Sensitivity of Quantitative 18F-Fdg-Pet Volumetric Measures to Background Activity Variation JO - Iranian Journal of Nuclear Medicine VL - 26 IS - 2 SP - 87 EP - 97 PY - 2018 ER - |